Overview
- ARK Invest, which bought 83,764 CoreWeave shares across March 30 to April 1, put about $6.9 million into the Nvidia‑partnered AI cloud provider as it posted 110% fourth‑quarter revenue growth but guided first‑quarter sales below forecasts.
- ARK took its first direct cap‑table position in OpenAI, acquiring 348,995 units across ARKF, ARKK, and ARKW through a Series C allocation.
- The firm added exposure to autonomous logistics, advanced energy, and genomics by buying Kodiak AI, Oklo, DoorDash, Arcturus Therapeutics, and GeneDx.
- ARK rebalanced by exiting 745,000 Strata Critical Medical shares and trimming positions in Teradyne, Pinterest, Veracyte, Discovery, and LY Corp.
- ARKK is down about 12% this year with roughly $1.2 billion in 12‑month outflows, while Wood touts a coming AI‑driven “great acceleration” and Bank of America upgraded CoreWeave to buy with a $100 target.